Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $708.88 million. The enterprise value is $1.03 billion.
| Market Cap | 708.88M |
| Enterprise Value | 1.03B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 165.24 million shares outstanding. The number of shares has increased by 3.27% in one year.
| Current Share Class | 165.24M |
| Shares Outstanding | 165.24M |
| Shares Change (YoY) | +3.27% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 3.24% |
| Owned by Institutions (%) | 84.78% |
| Float | 136.77M |
Valuation Ratios
The trailing PE ratio is 5.44 and the forward PE ratio is 3.42.
| PE Ratio | 5.44 |
| Forward PE | 3.42 |
| PS Ratio | 1.82 |
| Forward PS | 1.49 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.82 |
| P/OCF Ratio | 3.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.31, with an EV/FCF ratio of 5.53.
| EV / Earnings | 7.91 |
| EV / Sales | 2.64 |
| EV / EBITDA | 4.31 |
| EV / EBIT | 4.35 |
| EV / FCF | 5.53 |
Financial Position
The company has a current ratio of 6.06
| Current Ratio | 6.06 |
| Quick Ratio | 5.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.65 |
| Debt / FCF | 2.14 |
| Interest Coverage | 7.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 47.02% |
| Return on Invested Capital (ROIC) | 65.68% |
| Return on Capital Employed (ROCE) | 93.66% |
| Weighted Average Cost of Capital (WACC) | 5.32% |
| Revenue Per Employee | $3.89M |
| Profits Per Employee | $1.30M |
| Employee Count | 100 |
| Asset Turnover | 1.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $77.51 million in taxes.
| Income Tax | 77.51M |
| Effective Tax Rate | 37.38% |
Stock Price Statistics
The stock price has increased by +290.00% in the last 52 weeks. The beta is 0.21, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +290.00% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 3.85 |
| Relative Strength Index (RSI) | 53.54 |
| Average Volume (20 Days) | 2,307,556 |
Short Selling Information
The latest short interest is 16.54 million, so 10.01% of the outstanding shares have been sold short.
| Short Interest | 16.54M |
| Short Previous Month | 17.19M |
| Short % of Shares Out | 10.01% |
| Short % of Float | 12.10% |
| Short Ratio (days to cover) | 7.62 |
Income Statement
In the last 12 months, IRWD had revenue of $389.32 million and earned $129.87 million in profits. Earnings per share was $0.79.
| Revenue | 389.32M |
| Gross Profit | 300.62M |
| Operating Income | 236.27M |
| Pretax Income | 207.38M |
| Net Income | 129.87M |
| EBITDA | 238.11M |
| EBIT | 236.27M |
| Earnings Per Share (EPS) | $0.79 |
Balance Sheet
The company has $79.13 million in cash and $396.87 million in debt, with a net cash position of -$317.74 million or -$1.92 per share.
| Cash & Cash Equivalents | 79.13M |
| Total Debt | 396.87M |
| Net Cash | -317.74M |
| Net Cash Per Share | -$1.92 |
| Equity (Book Value) | -161.84M |
| Book Value Per Share | -0.98 |
| Working Capital | 166.35M |
Cash Flow
In the last 12 months, operating cash flow was $185.56 million and capital expenditures -$1,000, giving a free cash flow of $185.55 million.
| Operating Cash Flow | 185.56M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 1.84M |
| Net Borrowing | -200.00M |
| Free Cash Flow | 185.55M |
| FCF Per Share | $1.12 |
Margins
Gross margin is 77.22%, with operating and profit margins of 60.69% and 33.36%.
| Gross Margin | 77.22% |
| Operating Margin | 60.69% |
| Pretax Margin | 53.27% |
| Profit Margin | 33.36% |
| EBITDA Margin | 61.16% |
| EBIT Margin | 60.69% |
| FCF Margin | 47.66% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.27% |
| Shareholder Yield | -3.27% |
| Earnings Yield | 18.32% |
| FCF Yield | 26.18% |
Analyst Forecast
The average price target for IRWD is $6.10, which is 42.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.10 |
| Price Target Difference | 42.19% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 19.11% |
| EPS Growth Forecast (3Y) | 83.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -2.34 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.34 |
| Piotroski F-Score | 7 |